E-Therapeutics PLC ETPPF:Grey Market

RT Quote | Exchange | USD
Last | 12/16/20 EDT
0.23UNCH (UNCH)
52 week range
0.16 - 0.23

...

Loading . . .
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.23
  • 52 Week High0.23
  • 52 Week High Date12/16/20
  • 52 Week Low0.16
  • 52 Week Low Date07/08/20

Key Stats

  • Market Cap120.68M
  • Shares Out419.06M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.23
  • 52 Week High0.23
  • 52 Week High Date12/16/20
  • 52 Week Low0.16
  • 52 Week Low Date07/08/20
  • Market Cap120.68M
  • Shares Out419.06M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.01
  • P/E (TTM)-18.42
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From E-Therapeutics PLC

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
e-Therapeutics Plc is a United Kingdom-based company, which provides computer-based drug discovery platform. The Company uses its Network-Driven Drug Discovery (NDD) platform to develop intellectual property protected and pre-clinical drug discovery programs. The Company utilizes its biological proficiency and computer-based platform to create and analyze network models of disease processes to identify patterns of proteins. NDD enables network analysis, data mining, machine...
Trevor Jones Ph.D.
Non-Executive Chairman
Ali Mortazavi
Chief Executive Officer
Karl Keegan Ph.D.
Chief Financial Officer
Address
17 Blenheim Office Park
Witney
OX29 8LN
United Kingdom